Vilmedica - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 165,573 | 158,812 | 213,883 | 268,074 | 145,028 | 99,566 | 40,899 | 36,530 |
| Profit before tax | -115,508 | -84,262 | -54,598 | -10,141 | -93,321 | -2,234 | 23,877 | -1,150,807 |
| Net profit | -115,508 | -84,262 | -54,598 | -10,141 | -93,321 | -2,234 | 23,566 | -1,151,178 |
| Equity | 789,977 | 705,715 | 651,117 | 640,976 | 547,656 | 545,422 | 568,988 | -582,190 |
| Liabilities | 653,255 | 689,766 | 709,817 | 680,770 | 726,065 | 667,540 | 627,744 | 617,218 |
| Non-current assets | 1,190,224 | 1,185,360 | 1,178,207 | 1,172,985 | 1,176,429 | 1,163,351 | 1,162,171 | 3,495 |
| Current assets | 253,008 | 210,121 | 182,727 | 148,761 | 97,292 | 49,463 | 34,455 | 31,533 |
| Total assets | 1,443,232 | 1,395,481 | 1,360,934 | 1,321,746 | 1,273,721 | 1,212,814 | 1,196,626 | 35,028 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 21,257 | 9,932 | 7,337 |
| Social insurance contributions | - | - | - | - | - | 3,142 | 3,101 | - |
|
Financial indicators
|
||||||||
| Revenue change y/y | -40.7% | -4.1% | +34.7% | +25.3% | -45.9% | -31.3% | -58.9% | -10.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -8.0% | -6.0% | -4.0% | -0.8% | -7.3% | -0.2% | 2.0% | -3286.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -14.6% | -11.9% | -8.4% | -1.6% | -17.0% | -0.4% | 4.1% | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -69.8% | -53.1% | -25.5% | -3.8% | -64.3% | -2.2% | 57.6% | -3151.3% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -69.8% | -53.1% | -25.5% | -3.8% | -64.3% | -2.2% | 58.4% | -3150.3% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.8 | 1.0 | 1.1 | 1.1 | 1.3 | 1.2 | 1.1 | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 19,290 | 18,150 | 22,916 | 44,679 | 23,204 | 23,896 | 10,442 | 16,236 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Vilmedica - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-04-20 | 2026-04-21 | 0.43 |
| 2026-03-29 | 2026-04-01 | 0.43 |
| 2026-03-25 | 2026-03-26 | 0.43 |
| 2025-04-16 | 2025-04-21 | 228.23 |
| 2023-02-17 | 2023-02-20 | 662.09 |
| 2022-02-17 | 2022-02-17 | 22.18 |
Vilmedica - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Vilmedica, UAB (code 110601858) is a private limited liability company engaged in wholesale of wood, construction materials and sanitary equipment. In 2025 the company generated EUR 36.5K in revenue, down 10.7% year on year and 63.3% below 2023 levels. The multi-year pattern shows a decline from EUR 99.6K in 2023 to EUR 40.9K in 2024 and further to EUR 36.5K in 2025. Profitability was volatile: the company posted a EUR 2.2K loss in 2023, a EUR 23.6K net profit in 2024, and then a EUR 1.15M net loss in 2025. The latest margin and return ratios were distorted by very small revenue and negative equity, so they mainly reflect financial stress rather than normal operating performance. Balance-sheet indicators also weakened sharply in 2025, with total assets at EUR 35.0K, equity at EUR -582.2K and liabilities at EUR 617.2K. Long-term assets were EUR 3.5K and short-term assets EUR 31.5K. Asset turnover was 1.04x, revenue per employee EUR 18.3K, and profit per employee deeply negative.